Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
BioCell Technology, headquartered in Germany, is a leading innovator in the biotechnology industry, specialising in the development of advanced nutritional supplements and health products. Founded in 1997, the company has established a strong presence in major operational regions across Europe and North America, focusing on enhancing human health through scientifically-backed formulations.
The core offerings of BioCell Technology include its flagship product, BioCell Collagen®, a patented ingredient renowned for its unique composition of hydrolysed collagen, chondroitin sulphate, and hyaluronic acid. This product stands out for its ability to support joint health, skin hydration, and overall wellness. With a commitment to quality and efficacy, BioCell Technology has garnered a notable market position, recognised for its contributions to the health and wellness sector.
-9 vs industry average
BioCell Technology’s score of 13 is lower than 9% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Health Services has typical carbon intensity
The Health Services industry has reduced its overall emissions by 23% since 2018
No reported emissions data is available for BioCell Technology yet.
BioCell Technology, headquartered in Germany (DE), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that BioCell Technology may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within an increasingly eco-conscious market, it may benefit from developing and communicating clear climate commitments to align with global sustainability trends.
No climate goals have been disclosed for BioCell Technology yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more